Start Date
October 31, 2022
Primary Completion Date
January 31, 2024
Study Completion Date
April 30, 2024
AZD0328
Active study drug
Placebo
Non-active study drug
Collaborators (1)
Helse Stavanger HF
OTHER_GOV
Michael J. Fox Foundation for Parkinson's Research
OTHER
Parkinson's UK
OTHER
AstraZeneca
INDUSTRY
Masaryk University
OTHER
Norges Parkinsonforbund, Norway
UNKNOWN
University of Exeter
OTHER
Stichting Lygature
UNKNOWN
Innovative Medicines Initiative
OTHER
King's College London
OTHER